<bill session="117" type="s" number="2025" updated="2023-03-08T20:12:35Z">
  <state datetime="2021-06-10">REFERRED</state>
  <status>
    <introduced datetime="2021-06-10"/>
  </status>
  <introduced datetime="2021-06-10"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to improve access to innovative new medical devices furnished to individuals with end state renal disease under part B of the Medicare program by establishing a new device add-on payment adjustment under such part.</title>
    <title type="display">Patient Access to ESRD New Innovative Devices Act</title>
    <title type="short" as="introduced">Patient Access to ESRD New Innovative Devices Act</title>
  </titles>
  <sponsor bioguide_id="C001056"/>
  <cosponsors>
    <cosponsor bioguide_id="C000174" joined="2021-06-10"/>
    <cosponsor bioguide_id="H001079" joined="2021-06-10"/>
    <cosponsor bioguide_id="S001191" joined="2021-06-10"/>
  </cosponsors>
  <actions>
    <action datetime="2021-06-10">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2021-06-10" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="4809" relation="unknown"/>
    <bill session="117" type="h" number="5331" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Department of Health and Human Services"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health care coverage and access"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2021-08-20T19:45:13Z" status="Introduced in Senate">Patient Access to ESRD New Innovative Devices Act

This bill requires the Centers for Medicare &amp; Medicaid Services (CMS) to provide a certain payment adjustment under the Medicare end-stage renal disease (ESRD) prospective payment system. Specifically, the CMS must provide for a three-year temporary add-on payment adjustment for new medical devices used to diagnose, treat, or manage ESRD. (CMS regulations currently provide a two-year temporary add-on payment adjustment.)</summary>
</bill>
